Van Baelen K, Geukens T, Maetens M, et al. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer. Ann Oncol Off J Eur Soc Med Oncol. 2022;33(8):769–85. https://doi.org/10.1016/j.annonc.2022.05.006.
Johnson K, Sarma D, Hwang ES. Lobular breast cancer series: imaging. Breast Cancer Res BCR. 2015;17:94. https://doi.org/10.1186/s13058-015-0605-0.
Mouabbi JA, Hassan A, Lim B, Hortobagyi GN, Tripathy D, Layman RM. Invasive lobular carcinoma: an understudied emergent subtype of breast cancer. Breast Cancer Res Treat. 2022;193(2):253–64. https://doi.org/10.1007/s10549-022-06572-w.
Hovis KK, Lee JM, Hippe DS, et al. Accuracy of preoperative breast MRI versus conventional imaging in measuring pathologic extent of invasive lobular carcinoma. J Breast Imaging. 2021;3(3):288–98. https://doi.org/10.1093/jbi/wbab015.
Article PubMed PubMed Central Google Scholar
Thomas M, Kelly ED, Abraham J, Kruse M Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early stage disease. Semin Oncol. 2019;46(2):121–32. . https://doi.org/10.1053/j.seminoncol.2019.03.002.
Moore MM, Borossa G, Imbrie JZ, et al. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg. 2000;231(6):877–82. https://doi.org/10.1097/00000658-200006000-00012.
Article CAS PubMed PubMed Central Google Scholar
Bahl M, Baker JA, Kinsey EN, Ghate SV. MRI predictors of tumor-positive margins after breast-conserving surgery. Clin Imaging. 2019;57:45–9. https://doi.org/10.1016/j.clinimag.2019.05.006.
Yeatman TJ, Cantor AB, Smith TJ, et al. Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg. 1995;222(4):549–59. https://doi.org/10.1097/00000658-199522240-00012. discussion 559–561.
Article CAS PubMed PubMed Central Google Scholar
Silverstein MJ, Lewinsky BS, Waisman JR, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 1994;73(6):1673–7. 10.1002/1097-0142(19940315)73:6%3C1673::aid-cncr2820730620%3E3.0.co;2-b.
Article CAS PubMed Google Scholar
van der Noordaa MEM, Ioan I, Rutgers EJ, et al Breast-conserving therapy in patients with cT3 breast cancer with good response to neoadjuvant systemic therapy results in excellent local control: A comprehensive cancer center experience. Ann Surg Oncol. 2021;28(12):7383–94. . https://doi.org/10.1245/s10434-021-09865-4.
Abel MK, Brabham CE, Guo R, et al. Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater. Am J Surg. 2021;221(1):32–6. https://doi.org/10.1016/j.amjsurg.2020.05.038.
Sledge GW, Chagpar A, Perou C. Collective wisdom: lobular carcinoma of the breast. Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet. 2016;35:18–21. https://doi.org/10.1200/EDBK_100002.
Mamtani A, Zabor EC, Rosenberger LH, Stempel M, Gemignani ML, Morrow M. Was reexcision less frequent for patients with lobular breast cancer after publication of the SSO-ASTRO margin guidelines? Ann Surg Oncol. 2019;26(12):3856–62. https://doi.org/10.1245/s10434-019-07751-8.
Article PubMed PubMed Central Google Scholar
Moran MS, Schnitt SJ, Giuliano AE, et al. Society of surgical oncology–American society for radiation oncology consensus guideline on margins for breast-Conserving surgery with Whole-Breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol. 2014;88(3):553–64. https://doi.org/10.1016/j.ijrobp.2013.11.012.
Conforti F, Pala L, Pagan E, et al. Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence. Breast Cancer Res. 2019;21(1):153. https://doi.org/10.1186/s13058-019-1234-9.
Article CAS PubMed PubMed Central Google Scholar
Hewitt KC, Miller P, Piper M, et al. Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: incidence and management strategies. Am J Surg. 2022;223(4):699–704. https://doi.org/10.1016/j.amjsurg.2021.05.021.
Switalla KM, Falade IO, Quirarte A, et al Positive margin rates after breast-conserving surgery by histologic subtype: a systematic review and Meta-analysis evaluating the impact of oncoplastic surgery. Ann Surg Oncol. 2025;32(7):4899–909. . https://doi.org/10.1245/s10434-025-17329-2.
Article PubMed PubMed Central Google Scholar
Mukhtar RA, Wong J, Piper M, et al. Breast conservation and negative margins in invasive lobular carcinoma: the impact of oncoplastic surgery and shave margins in 358 patients. Ann Surg Oncol. 2018;25(11):3165–70. https://doi.org/10.1245/s10434-018-6682-4.
Falade I, Switalla K, Quirarte A, et al Oncologic safety of immediate oncoplastic surgery compared with standard breast-conserving surgery for patients with invasive lobular carcinoma Ann Surg Oncol. 2024;31(11):7409–17. https://doi.org/10.1245/s10434-024-15326-5.
Article PubMed PubMed Central Google Scholar
Banys-Paluchowski M, Kühn T, Masannat Y, et al. Localization techniques for Non-Palpable breast lesions: current Status, knowledge Gaps, and rationale for the MELODY study (EUBREAST-4/iBRA-NET, NCT 05559411). Cancers. 2023;15(4):1173. https://doi.org/10.3390/cancers15041173.
Article CAS PubMed PubMed Central Google Scholar
Guirguis MS, Checka C, Adrada BE, et al. Bracketing with multiple radioactive seeds to achieve negative margins in breast conservation surgery: multiple seeds in breast surgery. Clin Breast Cancer. 2022;22(2):e158–66. https://doi.org/10.1016/j.clbc.2021.05.013.
Crown A, Laskin R, Rocha FG, Grumley J. Extreme oncoplasty: expanding indications for breast conservation. Am J Surg. 2019;217(5):851–6. https://doi.org/10.1016/j.amjsurg.2019.01.004.
Hossino D, Silverstein MJ, Savalia N, Jayich M, Khan S. Extreme oncoplasty: oncologically safe when compared with mastectomy. Ann Surg Oncol. 2024;31(11):7284–8. https://doi.org/10.1245/s10434-024-15791-y.
Article PubMed PubMed Central Google Scholar
Cocco D, ElSherif A, Wright MD, et al. Invasive lobular breast cancer: data to support surgical decision making. Ann Surg Oncol. 2021;28(10):5723–9. https://doi.org/10.1245/s10434-021-10455-7.
Mann RM, Cho N, Moy L, Breast MRI. State of the Art. Radiology. 2019;292(3):520–36. https://doi.org/10.1148/radiol.2019182947.
Moloney BM, McAnena PF, Ryan ÉJ, et al. The impact of preoperative breast magnetic resonance imaging on surgical management in symptomatic patients with invasive lobular carcinoma. Breast Cancer Basic Clin Res. 2020;14:1178223420948477. https://doi.org/10.1177/1178223420948477.
Ha SM, Chae EY, Cha JH, Kim HH, Shin HJ, Choi WJ. Breast MR imaging before surgery: outcomes in patients with invasive lobular carcinoma by using propensity score matching. Radiology. 2018;287(3):771–7. https://doi.org/10.1148/radiol.2018171472.
Houssami N, Turner RM, Morrow M. Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer. Breast Cancer Res Treat. 2017;165(2):273–83. https://doi.org/10.1007/s10549-017-4324-3.
Article PubMed PubMed Central Google Scholar
Cozzi A, Di Leo G, Houssami N, et al Preoperative breast MRI reduces reoperations for unilateral invasive lobular carcinoma: a patient-matched analysis from the MIPA study. Eur Radiol. Published online February 28, 2025. https://doi.org/10.1007/s00330-024-11338-7.
National Comprehensive Cancer Center. Clinical practice guidelines in oncology. Published online January 2024.
Vertido A, McKenzie T, Othieno A, et al Accuracy of breast MRI for surgical planning after neoadjuvant therapy for patients with invasive lobular carcinoma Ann Surg Oncol. Published online June 27, 2025. https://doi.org/10.1245/s10434-025-17735-6.
Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol JACR. 2018;15(3 Pt A):408–14. https://doi.org/10.1016/j.jacr.2017.11.034.
Comments (0)